Erivedge Approved to Treat Basal Cell Carinoma
Kalydeco Approved to Treat Rare Form of Cystic Fibrosis
MONDAY, January 30 (Healthday News) -- Erivedge (vismodegib) has been approved by the U.S. Food And Drug Administration to treat the most common form of skin cancer, basal cell carcinoma, the agency said Monday. read more..
source:http://yhoo.it/zG2qeJ
Kalydeco Approved to Treat Rare Form of Cystic Fibrosis
TUESDAY, Jan. 31 (Healthday News) -- Kalydeco (ivacaftor) has been approved by the U.S. Food And Drug Administration to treat the root cause of a rare form of the inherited disease cystic fibrosis. read more..
source:http://yhoo.it/wnqDGP
No comments:
Post a Comment